a. CLIENT REGISTRATION AND VALIDATION

i. The client presents a valid identification for drug testing to the Screening DTC. If no valid identification is presented, the client is rejected for drug testing.

ii. The client fills up the Client Information Sheet (CIS) that serves as input in verifying his/her name and/or identity if there are any pending transactions from other DTCs.

iii. The Screening DTC opens the web-based Client Verification System to validate if the client has any pending transactions. The client is automatically rejected for drug testing if there are pending transactions from other DTCs. If there are no pending transactions, the client pays the corresponding amount for the drug test.

b. SPECIMEN COLLECTION

i. The Screening DTC issues the Custody and Control Form (CCF) to the specimen collector. The specimen collector informs the client on the correct procedures for specimen collection and allows client to select the specimen container.

ii. The client provides the specimen in accordance with the instructions given by the specimen collector. While waiting for the specimen to be given, the specimen collector fills up item 1 of the CCF without writing the name, address, age, sex, requesting party’s name and address on the second and third copies of the CCF. These copies are given to the laboratory to ensure that the laboratory personnel have no knowledge of the client’s name.

iii. The client gives the specimen to the specimen collector. The specimen collector fills up step 2 of the CCF.

iv. The specimen collector affixes bottle seal(s) to the bottle(s) and dates the seal(s). The client initials seal(s).

v. The specimen collector fills up and signs step 4 of the CCF. The client fills up and signs step 5 of the CCF.

vi. The specimen collector gives the first copy of the CCF to the client; the specimen, second and third copies of the CCF to the laboratory for accession and testing.

c. LABORATORY DRUG TESTING

i. The laboratory receives the specimen and CCF copies and provides a laboratory accession number, fills up and signs step 4 of the CCF.

ii. The analyst conducts the drug test, fills up and signs step 6 of the CCF.

iii. The analyst enters the results into the software and generates the DTR for negative results and other related reports. The DTR is not issued to client with positive results because the specimen has to be tested by the Confirmatory Laboratory.

iv. For positive result, the Screening DTC sends the specimen and a copy of the CCF to a Confirmatory Laboratory for another drug tests to confirm the result.

d. CONFIRMATORY LABORATORY DRUG TESTING FOR POSITIVE RESULTS

i. The Confirmatory Laboratory receives the specimen and a copy of the CCF.

ii. The Confirmatory Laboratory conducts the required tests, fills up and signs step 7 of the CCF and writes the Confirmatory DTR. The confirmatory result can be negative or positive.

iii. The Confirmatory Laboratory submits the Confirmatory DTR and CCF to the Screening DTC. The Screening DTC enters the Confirmatory results into the software and generates the DTR. The DTR can be challenged by a court order and the specimen is send to the National Reference Laboratory for final testing.

e. NATIONAL REFERENCE LABORATORY (NRL) FOR CHALLENGED DRUG TEST REPORT

i. With a court order, the client can challenge the drug test result and the Screening DTC sends the specimen and copy of the CCF to the NRL.

ii. The NRL conducts the required drug tests, fills up and signs step 8 of the CFF and writes the NRL DTR.

iii. The NRL submits the NRL DTR and CCF to the Screening DTC. The Screening DTC enters the NRL results into the software and generates the DTR.

f. DRUG TEST REPORT RELEASING

i. The analyst/medical technologist and head of the laboratory signs the DTR.

ii. The Screening DTC releases the DTR to the client.